|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.000100 USD | -.--% |
|
-.--% | - |
| 5 years | 0 |  | 0.03 |
| Manager | Title | Age | Since |
|---|---|---|---|
Michael Cohen
CEO | Chief Executive Officer | 60 | - |
| Director of Finance/CFO | 78 | 02/08/2012 | |
Steven Byle
CTO | Chief Tech/Sci/R&D Officer | 58 | 01/05/2009 |
| Director | Title | Age | Since |
|---|---|---|---|
Michael Cohen
CHM | Chairman | 60 | 20/01/2010 |
Steven Byle
BRD | Director/Board Member | 58 | 09/11/2009 |
Roger Fidler
BRD | Director/Board Member | 75 | 30/12/2009 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | - | - | 0 | |
| +0.46% | +11.03% | +35.48% | +0.74% | 76.75B | |
| -1.83% | -10.32% | +20.42% | +182.81% | 50.46B | |
| +1.54% | +2.37% | -6.31% | +23.71% | 48.5B | |
| +1.30% | +3.35% | -50.46% | -50.08% | 44.14B | |
| -0.17% | -1.41% | +55.23% | -23.29% | 30.53B | |
| -1.19% | -6.86% | +52.31% | +86.04% | 24.28B | |
| -4.26% | -1.16% | +96.07% | -50.22% | 22.46B | |
| +0.72% | +1.39% | -7.90% | +177.29% | 20.04B | |
| +1.13% | -5.79% | +62.11% | +120.47% | 16.14B | |
| Average | +0.46% | -0.41% | +28.55% | +51.94% | 33.33B | |
| Weighted average by Cap. | +0.40% | +1.06% | +21.53% | +41.91% |
Employees
-
Sector
Pharmaceuticals
- Stock Market
- Stocks
- PROT Stock
Select your edition
All financial news and data tailored to specific country editions
